216662-57-6

Basic information

• Product Name: (1S,3R,4R,5R)-3,4-O-Benzylidene-1,3,4-trihydroxy-6-oxabicyclo<3.2.1>octan-7-one
• Synonyms: (1S,3R,4R,5R)-3,4-O-Benzylidene-1,3,4-trihydroxy-6-oxabicyclo<3.2.1>octan-7-one
• CAS NO: 216662-57-6
• Molecular Weight: 262.262
• Mol File: 216662-57-6.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: (1S,3R,4R,5R)-3,4-O-Benzylidene-1,3,4-trihydroxy-6-oxabicyclo<3.2.1>octan-7-one(CAS DataBase Reference)
• NIST Chemistry Reference: (1S,3R,4R,5R)-3,4-O-Benzylidene-1,3,4-trihydroxy-6-oxabicyclo<3.2.1>octan-7-one(216662-57-6)
• EPA Substance Registry System: (1S,3R,4R,5R)-3,4-O-Benzylidene-1,3,4-trihydroxy-6-oxabicyclo<3.2.1>octan-7-one(216662-57-6)

Safety Data

• Hazardous Substances Data: 216662-57-6(Hazardous Substances Data)

Upstream product

• 6192-52-5 p-toluenesulfonic acid monohydrate 
• 77-95-2 D-(-)-quinic acid 
• 100-52-7 benzaldehyde 

Downstream Products

• 127604-97-1 methyl (1R,3R,4R)-4-[(tert-butyldimethylsilyl)oxy]-3-methoxycyclohexane-1-carboxylate 
• 128209-97-2 (1R,3R,4R)-4-[(tert-butyldimethylsilyl)oxy]-3-methoxycyclohexane-1-carbaldehyde 
• 133429-54-6 methyl (1R,3R,4R)-4-benzoyloxy-3-methoxycyclohexane-1-carboxylate 
• 158981-05-6 methyl (1R,3R,4R)-4-benzoyloxy-3-hydroxycyclohexane-1-carboxylate 
• 133407-51-9 (1S,3S,4S,5R)-4-benzoyloxy-3-bromo-6-oxabicyclo[3.2.1]octan-7-one 
• 133407-52-0 (1R,4R,5R)-4-benzoyloxy-6-oxabicyclo[3.2.1]octan-7-one 
• 128684-89-9 (1R,3R,4R) methyl 4-hydroxy-3-methoxy-1-cyclohexanecarboxylate 
• 155386-29-1 (1R,2R,4R)-1-[(tert-butyldimethylsilyl)oxy]-2-methoxy-4-(1-propynyl)cyclohexane 
• 155386-28-0 (1R,2R,4R)-1-[(tert-butyldimethylsilyl)oxy]-4-ethynyl-2-methoxycyclohexane 
• 155386-27-9 (1R,2R,4R)-1-[(tert-butyldimethylsilyl)oxy]-4-(2,2-dibromovinyl)-2-methoxycyclohexane 
• 65318-21-0 mycosporine glycine 
• 123641-67-8 C₂₉H₃₀NO₄P 
• 123641-68-9 Mycosporin-gly benzyl ester acetonide 
• 123641-61-2 (5R,7R,9S)-7-(Benzoyloxy)-9-bromo-2,2-dimethyl-1,3-dioxaspiro<4.5>decan-8-one 

Relevant articles and documents

A novel efficient and versatile route to the synthesis of 5-O-feruloylquinic acids

A novel synthesis of 5-O-feruloylquinic acid, a polyphenolic compound found in coffee beans, and its methyl ester derivative has been optimized. The sequence involves 6 steps and is compatible with the preparation of potential human metabolites of these c

Design, synthesis, and neuraminidase inhibitory activity of GS-4071 analogues that utilize a novel hydrophobic paradigm.

Structure-based design has led to the synthesis of a novel analogue of GS-4071, an influenza neuraminidase inhibitor, in which the basic amino group has been replaced by a hydrophobic vinyl group. An X-ray co-crystal structure of the new inhibitor (K(i)=4

Transformations of quinic acid. Asymmetric synthesis and absolute configuration of mycosporin I and mycosporin-gly

D-(-)-Quinic acid (1) was converted to the fungal metabolites mycosporin I (2) and mycosporin-gly (13) via the iminophosphorane 64. The latter was prepared in 10 steps from 1 using oxidative bromination of quinide 33 to furnish 41. Reduction of the γ-lact